Monitoring Tumor Therapy
نویسندگان
چکیده
منابع مشابه
Monitoring of therapy in androgen-dependent prostate tumor model by measuring tumor proliferation.
UNLABELLED 3'-Deoxy-3'-(18)F-fluorothymidine ((18)F-FLT) has been recently described as a radiopharmaceutical for measuring cellular proliferation using PET imaging. Evaluation of tumor proliferative activity by PET using (18)F-FLT could be a procedure to assess the viability of tumor, such as histologic grade, clinical stage, and prognosis as well as the early effects of cancer therapy. This s...
متن کاملTumor Marker Monitoring
Reduce cost of care An obvious goal is to enhance patient care. We have to remember that tumor markers are not treatments and that the relevance of tumor markers for particular cancers are only as good as the treatments allow them to be. The other speakers have made that observation also. So how can tumor markers enhance patient care? Hopefull~ they can extend survival time and improve the qual...
متن کاملMonitoring of osteoporosis therapy.
Over the past two decades, major advances have been made in the number and range of agents available for the treatment of osteoporosis, all with proven anti-fracture efficacy. Unfortunately, compliance with these treatments is not optimal, and a number of patients could be considered as non-responders. Consequently, monitoring anti-osteoporotic therapy could be part of successful osteoporosis m...
متن کاملMonitoring osteoporosis therapy.
Osteoporosis is a prevalent condition that may exist in a silent form, in which increased fracture risk can be detected by measurement of bone mineral density (BMD), or as a symptomatic condition after a fragility fracture has occurred. In October 2004, the Surgeon General of the United States published a lengthy report on osteoporosis (1 ), which is a must-read for healthcare professionals int...
متن کاملMonitoring Radiographic Brain Tumor Progression
Determining radiographic progression in primary malignant brain tumors has posed a significant challenge to the neuroncology community. Glioblastoma multiforme (GBM, WHO Grade IV) through its inherent heterogeneous enhancement, growth patterns, and irregular nature has been difficult to assess for progression. Our ability to detect tumor progression radiographically remains inadequate. Despite ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Current Protocols in Magnetic Resonance Imaging
سال: 2001
ISSN: 2572-5637,2572-5637
DOI: 10.1002/0471142719.mia0305s00